TY  - CHAP
AU  - Elien Derveaux
AU  - Evelyne Louis
AU  - Karolien Vanhove
AU  - Liene Bervoets
AU  - 
Liesbet Mesotten
AU  - Michiel Thomeer
AU  - Peter Adriaensens
ED  - Alba Fabiola Costa Torres
Y1  - 2018-11-05
PY  - 2018
T1  - Diagnosis of Lung Cancer: What Metabolomics Can Contribute
N2  - Among the deadliest type of cancers, lung cancer faces several challenges in diagnosis and treatment: late diagnosis and misdiagnosis, inadequate tumor sampling, and resistance development to current therapies, among others. Together with advances in the understanding of molecular features, factors, and mechanisms involved in initiation and tumor progression, important improvements have occurred in diagnostics and therapeutics in the shape of advances in molecular genotyping, procedures for sampling, new potential, and less invasive sources of samples for the diagnosis and development of new targeted therapies. The aim of this book is to provide an exciting read on strategies in the diagnosis and therapy of lung cancer.
BT  - Lung Cancer
SP  - Ch. 4
UR  - https://doi.org/10.5772/intechopen.79258
DO  - 10.5772/intechopen.79258
SN  - 978-1-78984-350-7
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-04-25
ER  -